BiotechTV

•

Channel • 5 Shows

Life Sciences

Life Sciences

Updated Jan 28
Life Sciences

Life Sciences

Updated Biweekly
Life Sciences

Life Sciences

Updated 12/19/2025
Life Sciences

Life Sciences

Updated 05/08/2025
Life Sciences

Life Sciences

Updated Feb 2

3D AGO

Episode 34: General Atlantic's Brett Zbar

Brett Zbar describes his early career, including working at Aisling Capital and Foresight Capital, and now managing the healthcare strategy at General Atlantic. He describes how he sees the difference between private equity and venture capital, and discusses which themes in biotech and healthcare appeal to him today.

3d ago

•

1h 7m
JAN 28

Corvus Pharma CEO Richard Miller fields follow-up questions about last week's atopic dermatitis data for the ITK inhibitor soquelitinib

He discusses learnings about durability, dosing, biomarkers, and more for this first-in-class target.

Jan 28

•

27 min
JAN 11

Episode 32: ARCH Venture Partners' Bob Nelsen

While describing his early life in Washington and formative years at the University of Chicago that led to the founding of ARCH, he shares his thoughts on leadership, risk taking, changes he thinks are need to keep the United States competitive in life sciences, and his belief in AI's promise to transform our industry.

Jan 11

•

1h 15m
JAN 26

Episode 33: Pappas Capital's Art Pappas

Art Pappas describes his early career, which involved numerous overseas posts for large companies, and how it let him to eventually found Pappas Capital. He discusses the various ways the firm invests, and how having corporates partners as LPs and co-investors has been a recipe for success.

Jan 26

•

58 min
JAN 22

Analysts Thursdays: Clear Street Senior Biotech Analyst Kaveri Pohlman shares her take on biotech for 2026 and discusses her top picks

She discusses Arrivent Biopharma, Oruka Therapeutics, Jade Biosciences, Zura Bio, and Pavella Therapeutics.

Jan 22

•

17 min
JAN 17

SF Healthcare Week: Perceptive Advisors' Joe Edelman, one of the top investors in biotech, shares his investment philosophy and his take on the sector heading into 2026

He talks about Perceptive's investment philosophy, his take on the year ahead, areas he thinks are over and under hyped, and thoughts on China. Plus, the rationale for a few of his top holdings.

Jan 17

•

11 min
12/29/2025

Episode 31: Polaris Partners' Amy Schulman

She describes her career beginnings as a lawyer, which led to general counsel and business unit head roles at Pfizer, and then joining the VC world at Polaris Partners (at Bob Langer's urging). She discusses the firm's investment philosophy, the nuances behind how companies choose lead assets, and the cycles biotech has been through over the last ten years. Plus, other roles she currently serves, including being the chair of Alnylam.

12/29/2025

•

1h 3m
JAN 16

SF Healthcare Week: Cytokinetics CEO Robert Blum discusses the approval and impending launch of the cardiomyopathy therapy MYQORZO

He discussed the REMS, launch plans, market opportunity, payors, and the metrics that the company will offer publicly over time. Plus, previewing a key new data readout that will be coming in the second quarter of this year.

Jan 16

•

12 min
09/22/2025

Episode 25: Atlas Venture's Bruce Booth

Bruce Booth discusses his education and early career, the structure of Atlas and the types of investments it makes, investing in assets vs platforms, and more.

09/22/2025

•

1h 18m
05/05/2025

Episode 18: Playground Global's Jory Bell

Jory Bell shares the details of his expansive educational background and early career, which included being a product designer at Apple during the return of Steve Jobs. He describes Playground's engineering and tech angle to investing in life sciences, and weighs in on sizable seed and pre-seed investments the industry has seen lately that get startups to a proof of concept.

05/05/2025

•

1h 17m

BiotechTV covers the biotechnology sector through news, stories, podcasts, and educational videos.

Website

BiotechTV

Top Shows

Episode 34: General Atlantic's Brett Zbar

Corvus Pharma CEO Richard Miller fields follow-up questions about last week's atopic dermatitis data for the ITK inhibitor soquelitinib

Episode 32: ARCH Venture Partners' Bob Nelsen

Episode 33: Pappas Capital's Art Pappas

Analysts Thursdays: Clear Street Senior Biotech Analyst Kaveri Pohlman shares her take on biotech for 2026 and discusses her top picks

SF Healthcare Week: Perceptive Advisors' Joe Edelman, one of the top investors in biotech, shares his investment philosophy and his take on the sector heading into 2026

Episode 31: Polaris Partners' Amy Schulman

SF Healthcare Week: Cytokinetics CEO Robert Blum discusses the approval and impending launch of the cardiomyopathy therapy MYQORZO

Episode 25: Atlas Venture's Bruce Booth

Episode 18: Playground Global's Jory Bell

About

BiotechTV

Top Shows

Top Episodes

About